BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Financials Beijing Balance Medical Technology Co.,Ltd.
Equities
688198
CNE100005X15
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.2 CNY | -3.33% |
|
-2.58% | -7.52% |
| Apr. 22 | Beijing Balance Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 28 | Balance Medical Technology's Profit Jumps 21% in 2023 | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,455 | 24,524 | 17,502 | 17,008 | 15,730 | - | - |
| Enterprise Value (EV) 1 | 7,455 | 24,524 | 17,502 | 17,008 | 15,730 | 15,730 | 15,730 |
| P/E ratio | 134 x | 480 x | 182 x | 148 x | 97.6 x | 71.5 x | 52.4 x |
| Yield | - | 0.2% | - | - | - | - | - |
| Capitalization / Revenue | - | 97.4 x | - | 45.9 x | 30.7 x | 22.7 x | 17 x |
| EV / Revenue | - | 97.4 x | - | 45.9 x | 30.7 x | 22.7 x | 17 x |
| EV / EBITDA | - | - | - | 128 x | 83.7 x | 57.8 x | 40.2 x |
| EV / FCF | - | 5,714,426,544 x | - | 1,323,958,996 x | - | - | - |
| FCF Yield | - | 0% | - | 0% | - | - | - |
| Price to Book | - | 24.8 x | - | 14.2 x | 12.6 x | 11.9 x | 10.9 x |
| Nbr of stocks (in thousands) | 134,400 | 135,014 | 135,673 | 136,579 | 136,579 | - | - |
| Reference price 2 | 55.47 | 181.6 | 129.0 | 124.5 | 115.2 | 115.2 | 115.2 |
| Announcement Date | 1/29/21 | 2/21/22 | 2/27/23 | 2/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 251.8 | - | 370.6 | 513 | 692 | 923 |
| EBITDA 1 | - | - | - | 132.5 | 188 | 272 | 391 |
| EBIT 1 | - | 52.61 | - | 120.8 | 179 | 247 | 343 |
| Operating Margin | - | 20.89% | - | 32.6% | 34.89% | 35.69% | 37.16% |
| Earnings before Tax (EBT) 1 | - | 49.76 | - | 120 | 178 | 246 | 342 |
| Net income 1 | 56.02 | 51.2 | 95.74 | 115.2 | 161 | 220 | 300 |
| Net margin | - | 20.33% | - | 31.08% | 31.38% | 31.79% | 32.5% |
| EPS 2 | 0.4143 | 0.3786 | 0.7100 | 0.8400 | 1.180 | 1.610 | 2.200 |
| Free Cash Flow | - | 4.292 | - | 12.85 | - | - | - |
| FCF margin | - | 1.7% | - | 3.47% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | 9.69% | - | - | - |
| FCF Conversion (Net income) | - | 8.38% | - | 11.15% | - | - | - |
| Dividend per Share | - | 0.3571 | - | - | - | - | - |
| Announcement Date | 1/29/21 | 2/21/22 | 2/27/23 | 2/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | 4.29 | - | 12.8 | - | - | - |
| ROE (net income / shareholders' equity) | - | 5.65% | - | 10.1% | 12.9% | 16.6% | 20.8% |
| ROA (Net income/ Total Assets) | - | - | - | 9.22% | 11.7% | 13.1% | 15% |
| Assets 1 | - | - | - | 1,250 | 1,376 | 1,679 | 2,000 |
| Book Value Per Share 2 | - | 7.330 | - | 8.750 | 9.130 | 9.710 | 10.60 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 72.2 | - | 128 | 250 | 250 | 250 |
| Capex / Sales | - | 28.67% | - | 34.62% | 48.73% | 36.13% | 27.09% |
| Announcement Date | 1/29/21 | 2/21/22 | 2/27/23 | 2/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
115.2
CNY
Average target price
138
CNY
Spread / Average Target
+19.82%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.52% | 2.18B | |
| +10.39% | 126B | |
| -6.86% | 10.96B | |
| +2.52% | 8.97B | |
| +38.96% | 5.56B | |
| -17.50% | 4.99B | |
| +8.36% | 3.44B | |
| -8.84% | 2.8B | |
| -3.00% | 2.16B | |
| -21.88% | 1.82B |
- Stock Market
- Equities
- 688198 Stock
- Financials Beijing Balance Medical Technology Co.,Ltd.
